The global growth and differentiation factor market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Growth differentiation factors (GDFs) are a subfamily of the transforming growth factor-beta superfamily of proteins that have a role in tissue development and cancer. The market is mainly driven due to the increasing prevalence of ovarian and breast cancer coupled with rising awareness regarding breast cancer.
In the UK, female breast cancer is the most common type of breast cancer and accounts for 552,000 of new cancer cases every year, as per the Cancer Research UK. Female breast cancer accounted for 11,399 fatalities in the UK, between 2015-2017. Moreover, the expenditure on breast cancer by the government and private industries for therapeutics and medicines supports the growth of the market. The global expenditure such as the total funding of government organizations and private organizations on breast cancer is high compared to other cancers. In October 2019, the Breast Cancer Research Foundation (BCRF) announced its $66 million commitment to fund breast cancer research for 2019-2020. The grants will support the work of nearly 275 scientists at leading academic and medical institutions across the globe. The world’s breast cancer organization Susan G. Komen, announced the research funding of $30.7 million for 98 research grants in 2017. The organization also focuses on new treatment and understanding of the most mortal forms and stages of breast cancer. Susan G. Komen provides funds for breast cancer research in 27 states and 7 countries including the US, Middle East and Latin America. It also involves in research for new screening technologies, treatments for metastatic types of breast cancer and differences in breast cancer consequences. The research funding opportunity is expected to offer an opportunity for the development of novel GDF therapies. This, in turn, will likely accelerate the growth of the global growth and differentiation factor market.
Market Coverage
Segment Covered-
Regions Covered-
Competitive Landscape- Pfizer Inc, Merck & Co, Inc., and Novartis International AG, among others.
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
Global Growth and Differentiation Factor Market Report by Segment
By Product hhhType
Global Growth and Differentiation Factor Market Report by Region
North America
Europe
Asia-Pacific
Rest of the World